These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 19516943

  • 1. Surgical results of growth hormone-secreting pituitary adenoma.
    Kim MS, Jang HD, Kim OL.
    J Korean Neurosurg Soc; 2009 May; 45(5):271-4. PubMed ID: 19516943
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 3. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis.
    Briceno V, Zaidi HA, Doucette JA, Onomichi KB, Alreshidi A, Mekary RA, Smith TR.
    Neurol Res; 2017 May; 39(5):387-398. PubMed ID: 28301972
    [Abstract] [Full Text] [Related]

  • 5. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
    Nishioka H, Fukuhara N, Horiguchi K, Yamada S.
    J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
    [Abstract] [Full Text] [Related]

  • 6. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
    Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
    Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
    [Abstract] [Full Text] [Related]

  • 7. The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes.
    Buliman A, Tataranu LG, Ciubotaru V, Cazac TL, Dumitrache C.
    J Med Life; 2016 Oct; 9(2):187-92. PubMed ID: 27453753
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    Taweesomboonyat C, Oearsakul T.
    World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
    [Abstract] [Full Text] [Related]

  • 9. [Transsphenoidal surgery of secretory and invasive pituitary adenomas (somatotropinoma or corticotropinoma)--own experiences].
    Zieliński G, Podgórski JK, Koziarski A, Potakiewicz Z, Warczyńska A, Zgliczyński W, Makowska A.
    Przegl Lek; 2004 Feb; 61(9):928-34. PubMed ID: 15803901
    [Abstract] [Full Text] [Related]

  • 10. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
    Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, Ceylan S.
    World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
    [Abstract] [Full Text] [Related]

  • 11. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
    Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH.
    J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
    [Abstract] [Full Text] [Related]

  • 12. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
    Santoro A, Minniti G, Ruggeri A, Esposito V, Jaffrain-Rea ML, Delfini R.
    Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion.
    Park HH, Kim EH, Ku CR, Lee EJ, Kim SH.
    World Neurosurg; 2018 Sep; 117():e280-e289. PubMed ID: 29906579
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results.
    Asha MJ, Takami H, Velasquez C, Oswari S, Almeida JP, Zadeh G, Gentili F.
    J Neurosurg; 2020 Nov 01; 133(5):1360-1370. PubMed ID: 31604330
    [Abstract] [Full Text] [Related]

  • 15. [Surgical treatment of invasive pituitary adenomas (somatotropinoma or corticotropinoma)].
    Zieliński G, Podgórski JK, Koziarski A, Warczyńska A, Zgliczyński W, Makowska A.
    Neurol Neurochir Pol; 2003 Nov 01; 37(6):1239-55. PubMed ID: 15174237
    [Abstract] [Full Text] [Related]

  • 16. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
    Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
    Neurosurg Focus; 2010 Oct 01; 29(4):E6. PubMed ID: 20887131
    [Abstract] [Full Text] [Related]

  • 17. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
    Bellut D, Hlavica M, Schmid C, Bernays RL.
    Neurosurg Focus; 2010 Oct 01; 29(4):E9. PubMed ID: 20887134
    [Abstract] [Full Text] [Related]

  • 18. Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature.
    Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Tamburrano G, Cantore G.
    Endocr Relat Cancer; 2003 Dec 01; 10(4):611-9. PubMed ID: 14713271
    [Abstract] [Full Text] [Related]

  • 19. Predictors of Remission of Acromegaly following Surgical Treatment in Growth Hormone-Secreting Pituitary Adenoma.
    Konar S, Yeole U, Shukla D, Bhat DI, Sadashiva N, Devi BI.
    J Neurol Surg B Skull Base; 2024 Jun 01; 85(3):261-266. PubMed ID: 38721370
    [Abstract] [Full Text] [Related]

  • 20. Determinants of immediate and long-term remission after initial transsphenoidal surgery for acromegaly and outcome patterns during follow-up: a longitudinal study on 659 patients.
    Guo X, Zhang R, Zhang D, Wang Z, Gao L, Yao Y, Deng K, Bao X, Feng M, Xu Z, Yang Y, Lian W, Wang R, Ma W, Xing B.
    J Neurosurg; 2022 Sep 01; 137(3):618-628. PubMed ID: 35171834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.